Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 5, 2010, Pages 753-761

  Ishikane, Shin ^a,b   Yamahara, Kenichi ^a   Sada, Masaharu ^a   Harada, Kazuhiko ^a,b   Kodama, Makoto ^c   Ishibashi Ueda, Hatsue ^a   Hayakawa, Kazuhide ^b   Mishima, Kenichi ^b   Iwasaki, Katsunori ^b   Fujiwara, Michihiro ^b   Kangawa, Kenji ^a   Ikeda, Tomoaki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Acute myocarditis; Allogeneic transplantation; Fetal membrane; Immunosuppression; Mesenchymal stem cells

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ACUTE DISEASE; ADIPOCYTE; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL INFILTRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; FETUS; FETUS MEMBRANE; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEAN ARTERIAL PRESSURE; MESENCHYMAL STEM CELL; MYOCARDITIS; NONHUMAN; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ACUTE DISEASE; ANIMALS; CELL PROLIFERATION; EXTRAEMBRYONIC MEMBRANES; HEART FUNCTION TESTS; INFLAMMATION; INJECTIONS, INTRAVENOUS; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDITIS; MYOCARDIUM; RATS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

RATTUS; SUS;

EID: 77957220920     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.07.019     Document Type: Article

References (40)

1. Levi D., Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Curr Opin Cardiol 2001, 16:77-83.
2. Feldman A.M., McNamara D. Myocarditis. N Engl J Med 2000, 343:1388-1398.
3. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
4. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
5. da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006, 119:2204-2213.
6. Nagaya N., Fujii T., Iwase T., Ohgushi H., Itoh T., Uematsu M., et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol 2004, 287:H2670-H2676.
7. Nagaya N., Kangawa K., Itoh T., Iwase T., Murakami S., Miyahara Y., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005, 112:1128-1135.
8. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006, 12:459-465.
9. Ohnishi S., Yanagawa B., Tanaka K., Miyahara Y., Obata H., Kataoka M., et al. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol 2007, 42:88-97.
10. Zhao P., Ise H., Hongo M., Ota M., Konishi I., Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005, 79:528-535.
11. Alviano F., Fossati V., Marchionni C., Arpinati M., Bonsi L., Franchina M., et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 2007, 7:11.
12. Ishikane S., Ohnishi S., Yamahara K., Sada M., Harada K., Mishima K., et al. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 2008, 26:2625-2633.
13. Ringden O., Uzunel M., Rasmusson I., Remberger M., Sundberg B., Lonnies H., et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006, 81:1390-1397.
14. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579-1586.
15. Kodama M., Matsumoto Y., Fujiwara M., Masani F., Izumi T., Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 1990, 57:250-262.
16. Kodama M., Matsumoto Y., Fujiwara M., Zhang S.S., Hanawa H., Itoh E., et al. Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ Res 1991, 69:1042-1050.
17. Wong R.K., Hagg E.U., Rabie A.B., Lau D.W. Bone induction in clinical orthodontics: a review. Int J Adult Orthod Orthognath Surg 2002, 17:140-149.
18. In 't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., de Groot-Swings G.M., Claas F.H., Fibbe W.E., et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004, 22:1338-1345.
19. Soncini M., Vertua E., Gibelli L., Zorzi F., Denegri M., Albertini A., et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 2007, 1:296-305.
20. Hanawa H., Tsuchida M., Matsumoto Y., Watanabe H., Abo T., Sekikawa H., et al. Characterization of T cells infiltrating the heart in rats with experimental autoimmune myocarditis. Their similarity to extrathymic T cells in mice and the site of proliferation. J Immunol 1993, 150:5682-5695.
21. S.Sauer H., Hescheler J., Wartenberg M. Cardiac differentiation of mesenchymal stem cells in sex mis-matched transplanted hearts: self-repair or just a visit?. Cardiovasc Res 2002, 56:357-358.
22. Barbash I.M., Chouraqui P., Baron J., Feinberg M.S., Etzion S., Tessone A., et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003, 108:863-868.
23. Muller P., Pfeiffer P., Koglin J., Schafers H.J., Seeland U., Janzen I., et al. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation 2002, 106:31-35.
24. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., Koo W.W., Gordon P.L., Neel M., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999, 5:309-313.
25. Koc O.N., Lazarus H.M. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 2001, 27:235-239.
26. Pereira R.F., Halford K.W., O'Hara M.D., Leeper D.B., Sokolov B.P., Pollard M.D., et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 1995, 92:4857-4861.
27. Nakamura Y., Wang X., Xu C., Asakura A., Yoshiyama M., From A.H., et al. Xenotransplantation of long-term-cultured swine bone marrow-derived mesenchymal stem cells. Stem Cells Mar 2007, 25:612-620.
28. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
29. Ortiz L.A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003, 100:8407-8411.
30. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002, 30:42-48.
31. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
32. Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
33. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003, 57:11-20.
34. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101(9):3722-3729.
35. Sato K., Ozaki K., Oh I., Meguro A., Hatanaka K., Nagai T., et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007, 109:228-234.
36. English K., Barry F.P., Field-Corbett C.P., Mahon B.P. IFN-γ and TNF-7alpha; differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett 2007, 110:91-100.
37. Sheng H., Wang Y., Jin Y., Zhang Q., Zhang Y., Wang L., et al. A critical role of IFNγ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res 2008, 18:846-857.
38. Ohtaki H., Ylostalo J.H., Foraker J.E., Robinson A.P., Reger R.L., Shioda S., et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A 2008, 105:14638-14643.
39. Nemeth K., Leelahavanichkul A., Yuen P.S., Mayer B., Parmelee A., Doi K., et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009, 15:42-49.
40. Dai W., Hale S.L., Martin B.J., Kuang J.Q., Dow J.S., Wold L.E., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005, 112:214-223.